Showing results (451-460 of 677) with videos related to

Sort By:
Pageof 68
Plos One|March 18, 2021
Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbiditiesKeith Sigel, Chung Yin Kong, Sadiq Rehmani, et al.
CHEST Pulmonary|October 11, 2024
Adaptation of a Tailored Lung Cancer Screening Decision Aid for People With HIVMeagan C Brown, Madison Snidarich, Jehan Z Budak, et al.
JAMA Network Open|July 15, 2021
Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19Michael E Ohl, Donald R Miller, Brian C Lund, et al.
Journal of Clinical Pathways : the Foundation of Value-Based Care|June 26, 2023
Post-COVID-19 Syndrome Clinical Pathway for the US Veterans Health AdministrationClaudia L Campos, Cristina Nguyen, Kristina Crothers, et al.
Obesity (Silver Spring, Md.)|December 18, 2020
BMI and Outcomes of SARS-CoV-2 Among US VeteransMcKenna C Eastment, Kristin Berry, Emily Locke, et al.
AIDS (London, England)|May 19, 2016
Association of chronic obstructive pulmonary disease with frailty measurements in HIV-infected and uninfected VeteransKathleen M Akgün, Janet P Tate, Krisann K Oursler, et al.
Archives of Pathology & Laboratory Medicine|December 1, 2015
Performance Characteristics of Adenoid Cystic Carcinoma of the Salivary Glands in Fine-Needle Aspirates: Results From the College of American Pathologists Nongynecologic Cytology ProgramZ Laura Tabatabai, Manon Auger, Daniel F I Kurtycz, et al.
Veterinary Dermatology|October 7, 2017
An unresponsive progressive pustular and crusting dermatitis with acantholysis in nine catsCatherine A Outerbridge, Verena K Affolter, Leslie A Lyons, et al.
Annals of the American Thoracic Society|March 2, 2019
Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease ExacerbationBrett C Bade, Eric C DeRycke, Christine Ramsey, et al.
Vaccine|April 3, 2022
Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trialJessica W Crothers, Elizabeth Ross Colgate, Kelly J Cowan, et al.
Pageof 68